Search clinical trials for: ibandronate

Total 85 results

Institute of Liver and Biliary Sciences, India

Not yet recruiting

Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.

Liver Cirrhosis | Hepatic Osteodystrophy

India
Shinshu University

Recruiting

Efficacy of Oral Ibandronate in Osteoporosis

Osteoporosis

Japan
Columbia University
University of California, Irvine; Osteoporosis Center of Armenia

Completed

Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate

Osteoporosis, Postmenopausal

Armenia
Pontifical Catholic University of Argentina

Completed

Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America

Osteoporosis

Argentina
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management

Total Knee Arthroplasty

China
Vastra Gotaland Region
Oslo University Hospital; Helsinki University Central Hospital; Skane University... and other collaborators

Active, not recruiting

Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD. (ScanCLAD)

Lung Transplantation | Allografts

Norway, Sweden, Finland, Denmark
Shanghai Mental Health Center

Suspended

Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome

Schizophrenia

China
University of Pennsylvania

Completed

Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use

Healthy Volunteers | Atypical Femur Fracture | Osteoporosis, With or Without Treatment | Bisphosphonate Treatment | Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ)

United States
Yeouido St. Mary's Hospital
Samsung Medical Center; Seoul National University Bundang Hospital

Completed

Use of Ibandronate in Diabetic Patients

Type 2 Diabetes | Osteoporosis, Postmenopausal

Korea, Republic of
Organon and Co
World Health Information Science Consultants, LLC

Completed

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Adenocarcinoma | Esophageal Cancer | Squamous Cell Carcinoma
Organon and Co

Completed

Study of Investigational Drug in Osteoporosis (MK-0217-908)

Postmenopausal Osteoporosis
Myovant Sciences GmbH

Completed

A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men

Healthy

United States
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaborators

Completed

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

Breast Cancer
Tocagen Inc.

Withdrawn

A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care (Toca7)

Newly Diagnosed High Grade Glioma (HGG)
Azienda Ospedaliero-Universitaria Careggi

Completed

Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors (BONADIUV)

Breast Cancer

Italy
Germans Trias i Pujol Hospital

Withdrawn

Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort

HIV Infections

Spain
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Completed

Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

United Kingdom
Washington University School of Medicine

Completed

Exome Sequencing for Atypical Femoral Fractures

Osteoporosis | Atypical Femoral Fractures | Bisphosphonate Therapy
M.D. Anderson Cancer Center
Roche Pharma AG

Completed

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Hematological Malignancies

United States
GlaxoSmithKline

Completed

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal
Tocagen Inc.

Completed

Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

Glioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

United States
Hoffmann-La Roche

Completed

MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis

Post Menopausal Osteoporosis

Australia, United Kingdom, United States, Brazil, Germany, South Africa, France, Spain, Switzerland, Italy, Canada, Hungary, Belgium, Mexico, Poland, Denmark, Norway, Czechia, Romania
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; Procter and Gamble

Completed

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

Post-menopausal Osteoporosis

United Kingdom
Assistance Publique - Hôpitaux de Paris
Transgene

Unknown

Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (ONCOVIRAC)

Glioblastoma | Brain Cancer

France
Hoffmann-La Roche

Withdrawn

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Pain | Neoplasm Metastasis | Bone Neoplasm

Greece
Hoffmann-La Roche

Terminated

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Pain | Neoplasm Metastasis | Bone Neoplasm

United States, Italy, Chile, Russian Federation, Hungary, United Kingdom, Poland, Guatemala, Germany, Mexico, Puerto Rico, Greece, Australia, Switzerland, Argentina, Panama
Hoffmann-La Roche

Terminated

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Pain | Neoplasm Metastasis | Bone Neoplasm

United States, Mexico, Germany, Russian Federation, Italy, Hungary, Belgium, Chile, France, Argentina, Australia, Switzerland, Guatemala, Puerto Rico, Poland, Panama, United Kingdom, Canada
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva

Post-Menopausal Osteoporosis

United States, Germany, United Kingdom, Spain, Italy, Hungary, Belgium, Mexico, Poland, Denmark, France, Norway, Brazil, Czechia
GlaxoSmithKline

Completed

Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate

Osteoporosis

Netherlands
Brigitte Jolles, MD

Terminated

Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis

Hip Necrosis | Aseptic Hip Necrosis

Switzerland
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

Post-Menopausal Osteopenia

France
Hoffmann-La Roche

Completed

ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Post Menopausal Osteoporosis

Philippines, Taiwan, Thailand, Hong Kong, Indonesia
Hoffmann-La Roche

Completed

A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo

Osteoporosis

United States
Hoffmann-La Roche

Completed

A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Pain; Bone Neoplasms; Neoplasm Metastasis

Bulgaria
Hoffmann-La Roche

Completed

A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

United States
Hoffmann-La Roche

Completed

PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia

Postmenopausal Osteoporosis

United States
Hoffmann-La Roche

Completed

A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Pain; Bone Neoplasms; Neoplasm Metastasis

Bulgaria
Hoffmann-La Roche

Completed

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

Belgium, Luxembourg, Austria, Greece, Ireland
Hoffmann-La Roche

No longer available

A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Postmenopausal Osteoporosis

Taiwan
Hoffmann-La Roche

Completed

A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

Germany
Hoffmann-La Roche

Completed

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

Postmenopausal Osteoporosis

United States
Alvogen Korea

Completed

Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis (DIOS)

Postmenopausal Women With Osteoporosis

Korea, Republic of
Hoffmann-La Roche

Completed

An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)

Breast Cancer

Hungary
GlaxoSmithKline

Completed

A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo

Osteoporosis

United States
Hoffmann-La Roche

Completed

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

Post-Menopausal Osteoporosis

Turkey, Albania, Bosnia and Herzegovina, Croatia, Macedonia, The Former Yugoslav Republic of, Serbia
Hoffmann-La Roche

Completed

A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

Postmenopausal Osteoporosis

Poland, Slovakia, Hungary, Russian Federation, Latvia, Romania, Slovenia
Hoffmann-La Roche

Completed

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

Post Menopausal Osteoporosis

United States
Hoffmann-La Roche
Roche Pharma AG

Terminated

Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma (COMPARE)

Multiple Myeloma

Germany
Hoffmann-La Roche
GlaxoSmithKline

Completed

A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.

Postmenopausal Osteoporosis

Finland
Hoffmann-La Roche

Completed

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

Post Menopausal Osteoporosis

United States, Puerto Rico

Search clinical trials for: ibandronate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations